Omaha, Nebraska
Phase 1 cancer trials in Omaha, NE
38 Phase 1 cancer studies are recruiting participants at sites in Omaha as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Omaha at a glance
- 38 studies are recruiting at a site in Omaha.
- By phase: Phase 1 (13), Phase 1/2 (25).
- By sponsor: industry (35), university, hospital or other (3).
- By research area: Breast Cancer (9), Lung Cancer (8), Lymphoma (8), Prostate Cancer (8), Pancreatic Cancer (3), Melanoma (2).
- Most recent update to one of these records: November 17, 2026.
Breast cancer studies recruiting in Omaha
Basic details from each study's public record (the 30 most recently updated of 38). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.
- Phase 1/2
- All ages
- All sexes
- Sponsor
- RayzeBio, Inc.
- Registry record
- NCT06590857 · updated
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- Nebraska Cancer Specialists - Midwest Cancer Center - Legacy
- Registry record
- NCT03424005 · updated
Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Novartis Pharmaceuticals
- Study site
- Nebraska Cancer Specialists
- Registry record
- NCT07660055 · updated
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Terremoto Biosciences Inc.
- Study site
- Nebraska Cancer Specialists
- Registry record
- NCT07109726 · updated
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Accent Therapeutics
- Study site
- University of Nebraska Medical Center
- Registry record
- NCT06799065 · updated
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Radiopharm Theranostics, Ltd
- Study sites
- Nebraska Cancer Specialists · XCancer
- Registry record
- NCT07189871 · updated
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Study site
- Nebraska Cancer Specialists - Omaha - Wright Street /ID# 247399
- Registry record
- NCT05005403 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Omaha, NE on ClinicalTrials.gov.
Lung cancer studies recruiting in Omaha
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- IDEAYA Biosciences
- Study site
- Nebraska Cancer Specialists
- Registry record
- NCT07277413 · updated
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Study site
- Oncology Hematology West, PC dba Nebraska Cancer Specialists
- Registry record
- NCT03460977 · updated
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Inhibrx Biosciences, Inc
- Study site
- Nebraska Cancer Specialists
- Registry record
- NCT04198766 · updated
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Tango Therapeutics, Inc.
- Study site
- Nebraska Cancer Specialists
- Registry record
- NCT06922591 · updated
Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Molecular Partners AG
- Study site
- Nebraska Cancer Specialists
- Registry record
- NCT07278479 · updated
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Exelixis
- Study site
- Exelixis Clinical Site #2
- Registry record
- NCT05176483 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Omaha, NE on ClinicalTrials.gov.
Prostate cancer studies recruiting in Omaha
RYZ711 Diagnostic Platform Study
- Phase 1/2
- Ages 18 and older
- Male participants
- Sponsor
- RayzeBio, Inc.
- Registry record
- NCT07862582 · updated
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- Phase 1/2
- Ages 18 and older
- Male participants
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Urology Cancer Center, PC
- Registry record
- NCT06800313 · updated
A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Aktis Oncology, Inc.
- Study site
- XCancer
- Registry record
- NCT07581184 · updated
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- AstraZeneca
- Registry record
- NCT06879041 · updated
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
- Phase 1/2
- Ages 18 to 99
- Male participants
- Sponsor
- AstraZeneca
- Registry record
- NCT07590934 · updated
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
- Phase 1/2
- Ages 18 and older
- Male participants
- Sponsor
- Pathos AI, Inc.
- Study site
- Nebraska Cancer Specialists
- Registry record
- NCT06785636 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Omaha, NE on ClinicalTrials.gov.
Melanoma studies recruiting in Omaha
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
- Phase 1/2
- Ages 18 to 90
- All sexes
- Sponsor
- Perspective Therapeutics
- Study site
- Nebraska Cancer Specialists
- Registry record
- NCT05655312 · updated
Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Omaha, NE on ClinicalTrials.gov.
Lymphoma studies recruiting in Omaha
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Phase 1/2
- Up to age 22
- All sexes
- Sponsor
- PedAL BCU, LLC
- Study sites
- Children's Hospital and Medical Center of Omaha · University of Nebraska Medical Center
- Registry record
- NCT04726241 · updated
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Umoja Biopharma
- Study site
- University of Nebraska Medical Center
- Registry record
- NCT06528301 · updated
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Incyte Corporation
- Study site
- The University of Nebraska Medical Center
- Registry record
- NCT07195916 · updated
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Curis, Inc.
- Study site
- Fred and Pamela Buffett Cancer Center
- Registry record
- NCT03328078 · updated
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- Phase 1/2
- Ages 16 to 75
- All sexes
- Sponsor
- Leland Metheny
- Study site
- University of Nebraska Medical Center
- Registry record
- NCT03104491 · updated
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Lyell Immunopharma, Inc.
- Study site
- University of Nebraska Medical Center
- Registry record
- NCT05826535 · updated
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- CellCentric Ltd.
- Study sites
- Nebraska Cancer Specialists · University of Nebraska Medical Center
- Registry record
- NCT04068597 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Omaha, NE on ClinicalTrials.gov.
Pancreatic cancer studies recruiting in Omaha
Lead-212 PSV359 Therapy for Patients With Solid Tumors
- Phase 1/2
- Ages 18 to 90
- All sexes
- Sponsor
- Perspective Therapeutics
- Study site
- Nebraska Cancer Specialists
- Registry record
- NCT06710756 · updated
Chemoprevention With Tamoxifen in Pre-Invasive Pancreas Mucinous Cystic Neoplasms Not Undergoing Immediate Resection
- Phase 1
- Ages 19 and older
- All sexes
- Sponsor
- University of Nebraska
- Study site
- University of Nebraska Medical Center
- Registry record
- NCT06320990 · updated
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study sites
- Nebraska Cancer Specialists · University of Nebraska Medical Center
- Registry record
- NCT06445062 · updated
Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Omaha, NE on ClinicalTrials.gov.
Ask about studies near Omaha
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections